CONTENTS
Summer 2026
Imaging and Sensing
SPOT LIGHT
Spatial biology is moving from research curiosity to clinical reality – and the results are already changing how we understand and treat disease. The key to unlocking its full potential lies in automated, reproducible, end-to-end workflows that turn tissue complexity into clear, actionable decisions.
Could next-generation analytical technologies unlock faster, more informative stress testing for viral vectors?
Discovery and Development
As regulatory agencies encourage the adoption of new approach methodologies, pharmaceutical developers are increasingly exploring human iPSC-derived models to improve translational predictivity.
Can artificial intelligence truly transform drug discovery without equally transforming the biology and data that underpin it?
Analytical measurement in drug development spans multiple attributes, from concentration and binding to quality, impurities, and function.
Before accepting a vial, bag or tissue sample, cell and gene therapy developers should ask three questions: is donor consent fit for purpose, was the right testing performed?
How can the industry bridge the gap between cell and gene therapy innovation and reliable large-scale manufacturing?
Animal testing in drug development is facing growing pressure as scientists and regulators adopt more human-relevant alternatives.
Manufacturing
In the fast-paced, competitive world of generics manufacturing, processes such as integrated-dissolution-absorption testing can mean the difference between firstto-market and obscurity.
Pharmaceutical manufacturers are rethinking operational resilience as connected systems, automation and infrastructure dependencies play a larger role in production.
A wave of small interfering RNA therapeutics targeting prevalent cardiometabolic diseases is anticipated to drive active pharmaceutical ingredients demand beyond the scale that existing manufacturing models were designed to support.
Will the next generation of blockbuster therapies be won by science alone or by the speed of manufacturing execution?
As regulators increasingly focus on individual accountability, can manufacturing leaders afford to treat data governance as a back-office function?
Digital
As more and more cell therapies move from experimental treatments to commercial realities, manufacturing remains the primary bottleneck to patient access.
Every artificial intelligence-assisted conclusion that makes it outside the walls of an R&D organisation is a scientific claim that eventually has to stand on its own.
Lab Design
In high-mix environments, inspection systems must first be flexible – everything else builds on that foundation.
As workforce turnover reshapes the industry, how can organisations preserve the knowledge that drives scientific progress?
Regulars
Our interrim editor discusses the wonderful contributions that IPT Summer has to offer.
IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing.
A collation of the top Pharma events for Summer 2026!
EXECUTIVE DIRECTOR
PMGroup Worldwide Ltd
Karl Equi
GROUP MANAGING EDITOR
PMGroup Worldwide Ltd
Iona Everson
DEPUTY EDITORS
Yasmin Nolan
SALES
Louise White
DESIGN
Peter May
FRONT COVER
ARMMY PICCA Shutterstock
DIGITAL EDITION
IPT Online
www.iptonline.com
CONTACT US
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
PRINTING
Pureprint Group
www.pureprint.com
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables,
Timworth Green,
IP31 1HS
c-cms.com
Tel: 01580 883841
Email: enquiries@c-cms.com
www.iptonline.com
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – April, July, October and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2026 Samedan Ltd
Pharmaceutical Publishers
Be sure to read our other publications...
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.